Heron Therapeutics Inc vs Vanguard Value Index Fund ETF — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Vanguard Value Index Fund ETF trades at $218.65. The key difference: Vanguard Value Index Fund ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | VTV | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | — |
52-Week High | $1.96 | $220.51 |
52-Week Low | $0.39 | $175.51 |
Enterprise Value | $189.36M | — |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →